BMOV  ≥98%

促销价¥{{model.attbuying.price}}

市场价¥0.00

累计销量0 累计评价0 人评论

别称 {{model.alias}}
中文名称 {{model.name}}
英文名称 {{model.enname}}
品牌 {{model.brand}}
CAS {{model.cas}}
分子式
分子量 {{model.molecularweight}}
MDL {{model.mdl}}
货号 {{model.procode}}
数量

+ -

库存{{model.attbuying.number}}
包装规格:10mg in glass bottle
溶解性:溶于DMSO(5mg/ml 加热)
产品描述:基本信息 产品编号: B60022 产品名称: BMOV CAS: 38213-69-3   储存条件 粉末 -20℃ 四年     分子式: C12H10O7V 溶于液体 -80℃ 两年 分子量 317.15 -20℃ 一个月 化学名:  (SP-5-31)-bis(3-hydroxy-2-methyl-4H-pyran-4-onato-O3,O4)oxo-vanadium, Bis(maltolato)oxovanadium(IV) Solubility (25°C):   体外:   DMSO 21mg/mL(66.21mM) Ethanol Insoluble Water Insoluble 体内(现配现用):   <1mg/ml表示微溶或不溶。 普西唐提供的所有化合物浓度为内部测试所得,实际溶液度可能与公布值有所偏差,属于正常的批间细微差异现象。 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;⼀旦配成溶液,请分装保存,避免反复冻融造成的产品失效。   制备储备液   浓度   溶液体积 质量   1mg   5mg   10mg 1mM 3.1531mL 15.7654mL 31.5308mL 5mM 0.6306mL 3.1531mL 6.3062mL 10mM 0.3153mL 1.5765mL 3.1531mL 50mM 0.0631mL 0.3153mL 0.6306mL   生物活性 产品描述 一种有效,可逆,竞争性和具有口服活性的光谱蛋白酪氨酸磷酸酶(PTP)抑制剂。是一种有效的胰岛素增敏剂。 靶点 IC50:126nM(HCPTPA),109nM(PTP1B),26nM(HPTPβ) and 201nM(SHP2) 体外研究 Bis(maltolato)oxovanadium(IV) treatment enhances the phosphorylation of the insulin receptor and of the insulin signalling key intermediate Akt. Bis(maltolato)oxovanadium(IV) (BMOV; 50μM) treatment also resultes in an increased glucose uptake in C2C12 cells 体内研究 Bis(maltolato)oxovanadium(IV) (BMOV; 0.75-3.0 mmol; intraperitoneal injection; twice weekly; for 6 weeks; C57BL/6J mice) treatment ameliorates the metabolic phenotype. Liver, skeletal muscle, and adipose tissue revealed a significantly reduced PTP activity in all analysed tissues compared to HFD mice Animal Model: C57BL/6J mice (4-6 weeks) fed with high-fat diet (HFD) Dosage: 0.75-3.0 mmol Administration: Intraperitoneal injection; twice weekly; for 6 weeks Result: Ameliorated the metabolic phenotype, as evidenced by reduced body weight, improved insulin sensitivity and glucose tolerance.
保存条件:-20℃